Pimblett Emily

Track

Insider profile

Performance

Overall performance
1.5
Performance over holding periods
1.5
30 days 90 days 120 days
Average return -15% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Pimblett Emily's trades of Climb Bio Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Climb Bio Inc (CLYM)
Transaction date
Planned sale
Price
82.41
Quantity 96,997 -33.1%
Value US$2,978,796
US Climb Bio Inc (CLYM)
Transaction date
Planned sale
Price
388.62
Quantity 32,008 +20.2%
Value US$4,218,563
US Climb Bio Inc (CLYM)
Transaction date
Planned sale
Price
224.63
Quantity 59,186 -49.3%
Value US$4,735,975
US Climb Bio Inc (CLYM)
Transaction date
Planned sale
Price
8.06
Quantity 9 -0.1%
Value US$73
US Climb Bio Inc (CLYM)
Transaction date
Planned sale
Price
8.18
Quantity 1,182 -13.5%
Value US$9,669
US Climb Bio Inc (CLYM)
Transaction date
Sale
Price
7.21
Quantity 1,245 -24.9%
Value US$8,982
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-20 2025-06-20
US Climb Bio Inc (CLYM)
PlS Planned sale
96,997 -33.1%
82.41
US$2,978,796 		96,997 -33.1% 82.41 US$2,978,796
2025-03-20 2025-03-20
US Climb Bio Inc (CLYM)
PlS Planned sale
32,008 +20.2%
388.62
US$4,218,563 		32,008 +20.2% 388.62 US$4,218,563
2024-12-20 2024-12-19
US Climb Bio Inc (CLYM)
PlS Planned sale
59,186 -49.3%
224.63
US$4,735,975 		59,186 -49.3% 224.63 US$4,735,975
2024-09-20 2024-09-20
US Climb Bio Inc (CLYM)
PlS Planned sale
9 -0.1%
8.06
US$73 		9 -0.1% 8.06 US$73
2024-09-20 2024-09-20
US Climb Bio Inc (CLYM)
PlS Planned sale
1,182 -13.5%
8.18
US$9,669 		1,182 -13.5% 8.18 US$9,669
2024-06-21 2024-06-20
US Climb Bio Inc (CLYM)
S Sale
1,245 -24.9%
7.21
US$8,982 		1,245 -24.9% 7.21 US$8,982